IM Cannabis Corp.
IMCC evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for IMCC—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
Market Cap
$1.6M
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Dec 31, 2025.
Run IM Cannabis Corp. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available IM Cannabis Corp. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
6
Total value held
$5K
| Holder | Shares | Value |
|---|---|---|
| bank of montreal /can/ | 11,910 | $4K |
| federation des caisses desjardins du quebec | 1,895 | $701 |
| national bank of canada /fi/ | 103 | $37 |
| osaic holdings, inc. | 33 | $12 |
| group one trading llc | 2 | $1 |
| royal bank of canada | 71 | $0 |
Short Interest
as of Apr 21, 2026- % of float
- 1.1%
- Days to cover
- 0.1
- Shares short
- 60,258
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
IMCC short interestFrequently asked questions
Who is the CEO of IM Cannabis Corp.?
Mr. Oren Shuster is the chief executive officer of IM Cannabis Corp. (IMCC).
Where is IM Cannabis Corp. headquartered?
IM Cannabis Corp. (IMCC) is headquartered in Vancouver, BC, Canada.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.